Roche Statements
RB
Roche Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
207.95
100
72.585
34.9
135.37
65.1
1.1
0.5
95.571
46
117.27
56.4
18.1
8.7
-2.581
-1.2
0.705
0.3
16.232
7.8
4.394
2.1
11.809
5.7
1.167
10.148
221.7
100
78.3
35.3
143.4
64.7
0.6
0.3
94.7
42.7
115.2
52
28.2
12.7
-2
-0.9
0.1
0.05
26.3
11.9
6.7
3
19.5
8.8
1.93
10.1
205.6
100
73.2
35.6
132.3
64.3
1.2
0.6
95.9
46.6
116.5
56.7
15.9
7.7
-1
-0.5
0.2
0.1
15
7.3
3.8
1.8
11.2
5.4
1.07
10.5
203
100
71.2
35.1
131.8
64.9
0.6
0.3
84
41.4
103.6
51
28.2
13.9
-1
-0.5
—
0
27.2
13.4
7.1
3.5
20.1
9.9
1.99
10.1
174.3
100
61
35
113.3
65
0.6
0.3
80.9
46.4
99.1
56.9
14.3
8.2
-0.9
-0.5
—
0
13.6
7.8
3.7
2.1
9.8
5.6
0.96
10.2
159.6
100
57.2
35.8
102.4
64.2
0.3
0.2
71.3
44.7
88.7
55.6
13.8
8.6
-1
-0.6
—
0
12.8
8
3.8
2.4
9
5.6
0.88
10.2
156.4
100
57.4
36.7
99
63.3
0.3
0.2
63.8
40.8
81.8
52.3
17.2
11
-2.6
-1.7
0.3
0.2
14.8
9.5
3.4
2.2
11.1
7.1
1.14
9.7
109.6
100
39.2
35.8
70.4
64.2
0.2
0.2
54.1
49.4
70
63.9
0.4
0.4
-1.4
-1.3
—
0
-1
-0.9
0.3
0.3
-1.1
-1.004
-0.11
9.9
140.1
100
50.1
35.8
90
64.2
0.5
0.4
64.9
46.3
81
57.8
9
6.4
-1
-0.7
—
0
7.8
5.6
2.7
1.9
5.2
3.7
0.55
9.3
134.7
100
48.9
36.3
85.8
63.7
0.5
0.4
64.6
48
78.9
58.6
6.9
5.1
-0.9
-0.7
—
0
6
4.5
1.5
1.1
4.1
3
0.42
9.9
127.8
100
46.9
36.7
80.9
63.3
1.2
0.9
69
54
73.4
57.4
7.5
5.9
-0.1
-0.08
-0.2
-0.2
6.7
5.2
4
3.1
2.3
1.8
0.27
8.6
129.2
100
47.9
37.1
81.3
62.9
0.1
0.08
74.2
57.4
77.4
59.9
3.8
2.9
0.1
0.08
0.1
0.08
3.9
3
—
0
3.9
3
0.4
9.9
122.2
44.8
77.4
0.9
67
71.1
6.3
-1.1
-0.1
4.9
3.7
1.1
0.11
9.9
126.3
47
79.3
0.1
71.1
74.4
5
0.2
0.1
5.3
—
5.3
0.53
9.9